This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.from Top Business News- News18.com
via IFTTT
Friday, May 29, 2020
Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir
This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.from Top Business News- News18.com
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment